At a glance
ClinicalIndex Comparison RecordN/ACompleted· 97 enrolled
Drug / intervention
TetraGraph on dominant hand +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Role of Sugammadex and Quantitative Monitoring in "Fast-Track Anesthesia" During Liver Transplantation
In Brief
An observational study evaluating TetraGraph on dominant hand and TetraGraph on non-dominant hand for Liver Transplant Surgery. Completed, enrolled 97 participants across 1 site.
Detailed Summary
The purpose of this research is to estimate the frequency of postoperative lasting muscle weakness in patients receiving Sugammadex after undergoing liver transplant surgery by using electromyographic device (EMG), such as TetraGraph.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Transplant Surgery
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedFeb 2022
Enrollment StartOct 2022
Primary CompletionJan 2025
TodayJul 2026
First PostedFeb 1, 2022
Enrollment StartOct 20, 2022
Primary CompletionJan 21, 2025
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 4.4 years ago
Interventions
TetraGraph on dominant handother
Using standard of care TetraGraph device on dominant hand
TetraGraph on non-dominant handother
Using standard of care TetraGraph device on non-dominant hand